IDEXo — Idex Biometrics ASA Cashflow Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- NOK39.08m
- NOK49.60m
- $0.84m
Annual cashflow statement for Idex Biometrics ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -26.9 | -32.5 | -32.7 | -26.6 | -14.6 |
Depreciation | |||||
Non-Cash Items | 2.32 | 3.2 | 2.35 | 1.33 | -8.46 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.478 | -0.07 | -2.37 | -3.33 | 2.97 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -23.3 | -27.5 | -31.4 | -27 | -17.5 |
Capital Expenditures | -0.333 | -0.141 | -0.267 | -0.243 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.101 | -0.002 | 0.107 | 0.247 | 0.272 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.232 | -0.143 | -0.16 | 0.004 | 0.272 |
Financing Cash Flow Items | -0.5 | — | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 17.4 | 54.1 | 14 | 22.2 | 7.92 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -6.83 | 26.5 | -17.6 | -4.77 | -9.34 |